Quarterly report pursuant to Section 13 or 15(d)

Share-Based Compensation - Summary of Activity Under Share-Based Compensation Plans (Detail)

v3.20.1
Share-Based Compensation - Summary of Activity Under Share-Based Compensation Plans (Detail) - USD ($)
$ / shares in Units, $ in Millions
 3 Months Ended 12 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Dec. 31, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Outstanding and nonvested as of December 31, 2019, Number of Shares 1,833,000    
Granted, Number of Shares 1,218,000    
Vested, Number of Shares (274,000)    
Forfeited, Number of Shares (25,000)    
Outstanding and nonvested as of March 31, 2020, Number of Shares 2,752,000   1,833,000
Number of Shares, Expected to vest as of March 31, 2020 2,431,000    
Outstanding and nonvested as of December 31, 2019, Weighted Average Grant Date Fair Value Per Share $ 49.49    
Granted, Weighted Average Grant Date Fair Value Per Share 37.65    
Vested, Weighted Average Grant Date Fair Value Per Share 49.21    
Forfeited, Weighted Average Grant Date Fair Value Per Share 46.47    
Outstanding and nonvested as of Mrach 31, 2020, Weighted Average Grant Date Fair Value Per Share 44.30   $ 49.49
Expected to vest as of March 31, 2020, Weighted Average Grant Date Fair Value Per Share $ 43.75    
SARs [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Number of Awards Outstanding, Beginning Balance 7,001,000    
Granted, Number of Awards 0 0  
Exercised, Number of Awards (105,000)    
Forfeited, Number of Awards (5,000)    
Number of Awards Outstanding, Ending Balance 6,891,000   7,001,000
Number of Awards Exercisable, Ending Balance 6,876,000    
Number of Awards Vested and expected to vest, Ending Balance 6,891,000    
Weighted Average Exercise Price Per Award Outstanding, Beginning Balance $ 27.85    
Exercised, Weighted Average Exercise Price Per Award 27.15    
Forfeited, Weighted Average Exercise Price Per Award 28.60    
Weighted Average Exercise Price Per Award Outstanding, Ending Balance 27.86   $ 27.85
Exercisable, Weighted Average Exercise Price Per Award, Ending Balance 27.85    
Weighted Average Exercise Price Per Award, Vested and expected to vest, Ending Balance $ 27.86    
Weighted Average Remaining Contractual Term Outstanding 5 years 1 month 6 days   5 years 4 months 24 days
Exercisable Weighted Average Remaining Contractual Term 5 years 1 month 6 days    
Weighted Average Remaining Contractual Term, Vested and expected to vest 5 years 1 month 6 days    
Aggregate Intrinsic Value Outstanding $ 21.5   $ 138.7
Exercisable, Aggregate Intrinsic Value 21.5    
Aggregate Intrinsic Value, Vested and expected to vest $ 21.5